145 related articles for article (PubMed ID: 15207259)
21. Neuronal ceroid lipofuscinosis in Devon cattle is caused by a single base duplication (c.662dupG) in the bovine CLN5 gene.
Houweling PJ; Cavanagh JA; Palmer DN; Frugier T; Mitchell NL; Windsor PA; Raadsma HW; Tammen I
Biochim Biophys Acta; 2006 Oct; 1762(10):890-7. PubMed ID: 16935476
[TBL] [Abstract][Full Text] [Related]
22. Localization of wild-type and mutant neuronal ceroid lipofuscinosis CLN8 proteins in non-neuronal and neuronal cells.
Lonka L; Salonen T; Siintola E; Kopra O; Lehesjoki AE; Jalanko A
J Neurosci Res; 2004 Jun; 76(6):862-71. PubMed ID: 15160397
[TBL] [Abstract][Full Text] [Related]
23. Novel interactions of CLN5 support molecular networking between Neuronal Ceroid Lipofuscinosis proteins.
Lyly A; von Schantz C; Heine C; Schmiedt ML; Sipilä T; Jalanko A; Kyttälä A
BMC Cell Biol; 2009 Nov; 10():83. PubMed ID: 19941651
[TBL] [Abstract][Full Text] [Related]
24. Proteolytic processing of the neuronal ceroid lipofuscinosis related lysosomal protein CLN5.
De Silva B; Adams J; Lee SY
Exp Cell Res; 2015 Oct; 338(1):45-53. PubMed ID: 26342652
[TBL] [Abstract][Full Text] [Related]
25. Developmental impairments of select neurotransmitter systems in brains of Cln3(Deltaex7/8) knock-in mice, an animal model of juvenile neuronal ceroid lipofuscinosis.
Herrmann P; Druckrey-Fiskaaen C; Kouznetsova E; Heinitz K; Bigl M; Cotman SL; Schliebs R
J Neurosci Res; 2008 Jun; 86(8):1857-70. PubMed ID: 18265413
[TBL] [Abstract][Full Text] [Related]
26. Loss of Cln5 leads to altered Gad1 expression and deficits in interneuron development in mice.
Singh Y; Leinonen H; Fazaludeen F; Jaronen M; Guest D; Buckley N; Byts N; Oksa P; Jalkanen K; Iqbal I; Huuskonen M; Savchenko E; Keksa-Goldsteine V; Chew S; Myllyharju J; Tanila H; Ooi L; Koistinaho J; Kanninen KM; Malm T
Hum Mol Genet; 2019 Oct; 28(19):3309-3322. PubMed ID: 31294445
[TBL] [Abstract][Full Text] [Related]
27. Complementary DNA cloning and characterization of RANDAM-2, a type I membrane molecule specifically expressed on glutamatergic neuronal cells in the mouse cerebrum.
Kotani M; Tajima Y; Osanai T; Irie A; Iwatsuki K; Kanai-Azuma M; Imada M; Kato H; Shitara H; Kubo H; Sakuraba H
J Neurosci Res; 2003 Sep; 73(5):603-13. PubMed ID: 12929128
[TBL] [Abstract][Full Text] [Related]
28. A mixed breed dog with neuronal ceroid lipofuscinosis is homozygous for a CLN5 nonsense mutation previously identified in Border Collies and Australian Cattle Dogs.
Villani NA; Bullock G; Michaels JR; Yamato O; O'Brien DP; Mhlanga-Mutangadura T; Johnson GS; Katz ML
Mol Genet Metab; 2019 May; 127(1):107-115. PubMed ID: 31101435
[TBL] [Abstract][Full Text] [Related]
29. Sialin expression in the CNS implicates extralysosomal function in neurons.
Aula N; Kopra O; Jalanko A; Peltonen L
Neurobiol Dis; 2004 Mar; 15(2):251-61. PubMed ID: 15006695
[TBL] [Abstract][Full Text] [Related]
30. Neuronal ceroid lipofuscinoses are connected at molecular level: interaction of CLN5 protein with CLN2 and CLN3.
Vesa J; Chin MH; Oelgeschläger K; Isosomppi J; DellAngelica EC; Jalanko A; Peltonen L
Mol Biol Cell; 2002 Jul; 13(7):2410-20. PubMed ID: 12134079
[TBL] [Abstract][Full Text] [Related]
31. A CLN5 mutation causing an atypical neuronal ceroid lipofuscinosis of juvenile onset.
Pineda-Trujillo N; Cornejo W; Carrizosa J; Wheeler RB; Múnera S; Valencia A; Agudelo-Arango J; Cogollo A; Anderson G; Bedoya G; Mole SE; Ruíz-Linares A
Neurology; 2005 Feb; 64(4):740-2. PubMed ID: 15728307
[TBL] [Abstract][Full Text] [Related]
32. Apoptotic photoreceptor loss and altered expression of lysosomal proteins in the nclf mouse model of neuronal ceroid lipofuscinosis.
Bartsch U; Galliciotti G; Jofre GF; Jankowiak W; Hagel C; Braulke T
Invest Ophthalmol Vis Sci; 2013 Oct; 54(10):6952-9. PubMed ID: 24084090
[TBL] [Abstract][Full Text] [Related]
33. Expression pattern of BM88 in the developing nervous system of the chick and mouse embryo.
Politis PK; Rohrer H; Matsas R
Gene Expr Patterns; 2007 Jan; 7(1-2):165-77. PubMed ID: 16949349
[TBL] [Abstract][Full Text] [Related]
34. Mutations in classical late infantile neuronal ceroid lipofuscinosis disrupt transport of tripeptidyl-peptidase I to lysosomes.
Steinfeld R; Steinke HB; Isbrandt D; Kohlschütter A; Gärtner J
Hum Mol Genet; 2004 Oct; 13(20):2483-91. PubMed ID: 15317752
[TBL] [Abstract][Full Text] [Related]
35. Autophagy-lysosome pathway alterations and alpha-synuclein up-regulation in the subtype of neuronal ceroid lipofuscinosis, CLN5 disease.
Adams J; Feuerborn M; Molina JA; Wilden AR; Adhikari B; Budden T; Lee SY
Sci Rep; 2019 Jan; 9(1):151. PubMed ID: 30655561
[TBL] [Abstract][Full Text] [Related]
36. A lysosomal enigma CLN5 and its significance in understanding neuronal ceroid lipofuscinosis.
Basak I; Wicky HE; McDonald KO; Xu JB; Palmer JE; Best HL; Lefrancois S; Lee SY; Schoderboeck L; Hughes SM
Cell Mol Life Sci; 2021 May; 78(10):4735-4763. PubMed ID: 33792748
[TBL] [Abstract][Full Text] [Related]
37. Induced Pluripotent Stem Cells Derived from a CLN5 Patient Manifest Phenotypic Characteristics of Neuronal Ceroid Lipofuscinoses.
Uusi-Rauva K; Blom T; von Schantz-Fant C; Blom T; Jalanko A; Kyttälä A
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28468312
[TBL] [Abstract][Full Text] [Related]
38. Brain gene expression profiles of Cln1 and Cln5 deficient mice unravels common molecular pathways underlying neuronal degeneration in NCL diseases.
von Schantz C; Saharinen J; Kopra O; Cooper JD; Gentile M; Hovatta I; Peltonen L; Jalanko A
BMC Genomics; 2008 Mar; 9():146. PubMed ID: 18371231
[TBL] [Abstract][Full Text] [Related]
39. AAV2-mediated CLN2 gene transfer to rodent and non-human primate brain results in long-term TPP-I expression compatible with therapy for LINCL.
Sondhi D; Peterson DA; Giannaris EL; Sanders CT; Mendez BS; De B; Rostkowski AB; Blanchard B; Bjugstad K; Sladek JR; Redmond DE; Leopold PL; Kaminsky SM; Hackett NR; Crystal RG
Gene Ther; 2005 Nov; 12(22):1618-32. PubMed ID: 16052206
[TBL] [Abstract][Full Text] [Related]
40. CLN5 is cleaved by members of the SPP/SPPL family to produce a mature soluble protein.
Jules F; Sauvageau E; Dumaresq-Doiron K; Mazzaferri J; Haug-Kröper M; Fluhrer R; Costantino S; Lefrancois S
Exp Cell Res; 2017 Aug; 357(1):40-50. PubMed ID: 28442266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]